In March 2025, the company declared new ideas for a immediate-to-consumer providing of its Wegovy weight loss drug. The company set up a different pharmacy, termed NovoCare, which might charge clients $499 monthly for access to the drug, lower than 50 percent the price of the drug by means of other pharmaceutical distribution networks.[fifty three]